ADMA-50.05%20.0%
DYN+125.80%20.0%
INSM-11.00%20.0%
IONS+33.18%20.0%
NBIX+25.75%20.0%
As of Aug 6, 2026, 4:25 AM ET
Rare Diseases '25: RNA Therapy & Protein Mod Constituents
ADMA Biologics, Inc.ADMA | 20.0% | 3.93% | 11.97% | 1.09% | 9.46% | -49.23% | -40.53% | -54.23% | -50.05% | $2.15B |
Dyne Therapeutics, Inc.DYN | 20.0% | 0.77% | 7.08% | 14.58% | 3.93% | 33.79% | 67.54% | 164.08% | 125.80% | $4.89B |
Insmed IncorporatedINSM | 20.0% | 0.27% | -7.39% | -11.22% | 0.43% | -43.11% | -33.69% | 34.83% | -11.00% | $21.46B |
Ionis Pharmaceuticals, Inc.IONS | 20.0% | -1.60% | -4.17% | -34.85% | 4.67% | -31.50% | -33.22% | 88.75% | 33.18% | $8.96B |
Neurocrine Biosciences, Inc.NBIX | 20.0% | -2.75% | -8.12% | -7.24% | -3.18% | 13.87% | 22.12% | 49.11% | 25.75% | $16.24B |
| Theme return | — | 0.12% | -0.13% | -7.61% | 3.04% | -17.03% | -7.48% | 55.46% | 22.87% | — |
| Average | 20.0% | 0.12% | -0.13% | -7.53% | 3.06% | -15.24% | -3.56% | 56.51% | 24.74% | $10.74B |
| Median | 20.0% | 0.27% | -4.17% | -7.24% | 3.93% | -31.50% | -33.22% | 49.11% | 25.75% | $8.96B |
| Std Dev | 0.0% | 2.29% | 8.14% | 16.27% | 4.25% | 33.01% | 42.12% | 71.27% | 58.58% | $7.16B |
| Min | 20.0% | -2.75% | -8.12% | -34.85% | -3.18% | -49.23% | -40.53% | -54.23% | -50.05% | $2.15B |
| Max | 20.0% | 3.93% | 11.97% | 14.58% | 9.46% | 33.79% | 67.54% | 164.08% | 125.80% | $21.46B |
| % Positive Tickers | 60.00% | 40.00% | 40.00% | 80.00% | 40.00% | 40.00% | 80.00% | 60.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Rare Diseases '25: RNA Therapy & Protein Mod tracks 5 publicly listed stocks in this theme: ADMA, DYN, INSM, IONS, NBIX. See the constituent table for details.